GlassScriptPhysician profile
Ann D Bigger
NPI 1659816296
$668.52
in general payments reported to CMS, 2019-2025
12 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195 · 2022: $41.88 · 2023: $81.50 · 2024: $167 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $126.56 | 2021-2023 | Acthar |
| Vifor Pharma, INC. | $88.93 | 2021-2025 | Veltassa |
| Sanofi-Aventis U.S. LLC | $73.77 | 2021-2022 | |
| Novo Nordisk INC | $73.75 | 2024-2025 | Wegovy, Ozempic |
| Veloxis Pharmaceuticals, INC. | $61.61 | 2022-2024 | Envarsus |
| Travere Therapeutics, INC. | $60.08 | 2024-2025 | Filspari |
| Abbvie INC. | $47.21 | 2024 | |
| Nestle Healthcare Nutrition INC. | $36.45 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.38 | 2025 | Livtencity |
| Alexion Pharmaceuticals, INC. | $23.62 | 2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.30 | 2024 | Jardiance |
| Abiomed | $19.86 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Bigger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.